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Complexins (Cpxs) and synaptotagmins regulate calcium-dependent exocytosis. A central helix in
Cpx confers speciﬁc binding to the soluble N-ethylmaleimide-sensitive factor-attachment protein
receptor (SNARE) fusion machinery. An accessory helix in the amino-terminal region inhibits mem-
brane fusion by blocking SNAREpin zippering. We now show that an amphipathic helix in the car-
boxy-terminal region of CpxI binds lipid bilayers and affects SNARE-mediated lipid mixing in a
liposome fusion assay. The substitution of a hydrophobic amino acid within the helix by a charged
residue abolishes the lipid interaction and the stimulatory effect of CpxI in liposome fusion. In con-
trast, the introduction of the bulky hydrophobic amino acid tryptophan stimulates lipid binding and
liposome fusion. This data shows that local Cpx–lipid interactions can play a role in membrane
fusion.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Intracellular membrane fusion is mediated and controlled by an
obligatory set of conserved protein families [1]. The core mem-
brane fusion machinery consists of cognate v(vesicle)-SNAREs
and t(target)-SNAREs, which can spontaneously fuse liposomes or
entire cells, when located on opposite membranes [2,3]. The for-
mation of trans-SNARE complexes (SNAREpins) between two
membranes starts at the amino-terminal, membrane-distal ends
of the so-called SNARE motifs, which are conserved coiled-coil re-
gions of 50–60 amino acids. A functional SNARE complex always
contains four SNARE motifs, classiﬁed as Qabc- and R-SNAREs [4–
7]. SNARE motifs assemble in a zipper-like fashion leading to a pro-
gressive approach of the membranes [8]. Finally, fully assembled
SNARE motifs form an extremely stable four-helix bundle and this
protein folding reaction sufﬁces to spontaneously merge the two
lipid bilayers [3,9].
Synaptic transmission and other forms of regulated exocytosis
require additional components that ensure signal-dependent
transmitter release. Two proteins – complexin (Cpx) and the cal-
cium sensor synaptotagmin – are intimately coupled to the trigger-
ing process [10]. Cpxs, small cytosolic proteins, regulate distinct
steps of the assembly and fusion reaction by contributing both
stimulatory and inhibitory activities [11–23]. Cpxs bind with low
afﬁnity to t-SNAREs, consisting of syntaxin 1 (stx1) and SNAP-25chemical Societies. Published by E
-sensitive factor-attachment
rg.de (T.H. Söllner).on the plasma membrane [21]. Using t-SNAREs reconstituted into
liposomes, it has been shown that the Cpx–t-SNARE interaction
can interfere with the docking of v-SNARE vesicles (containing
VAMP2/synaptobrevin2) and SNAREpin formation [21]. In contrast,
when Cpx is incubated with liposomes, which are already bridged
by SNAREpins, Cpx stabilizes SNAREpins and stimulates membrane
fusion [20,21]. Structural and functional studies revealed a poten-
tial molecular mechanism for the dual roles of Cpxs. Cpxs contain
an unstructured amino-terminal domain (amino acids 1–25), fol-
lowed by a so-called accessory inhibitory helix (aa 26–47), a cen-
tral helix (aa 48–70) and an unstructured carboxy-terminal
domain (aa 71–134). The central helix of Cpx binds with high afﬁn-
ity in an anti-parallel manner to the assembled four-helix SNARE
bundle [24]. The binding site is provided by a groove formed by
VAMP2 and stx1 and covers the central portion of the SNARE bun-
dle. In such fully assembled SNARE complexes, the accessory helix
of Cpx, which is located close to the membrane proximal region of
the SNAREs, does not directly interact with the SNARE four-helix
bundle. In contrast, in a partially assembled SNAREpin the acces-
sory helix apparently binds the membrane proximal part of the
t-SNARE and thereby competes with VAMP2 for t-SNARE binding
(see also model in Fig. 4) [14,19]. In this scenario Cpx inhibits
SNAREpin zippering. This model can explain the incubation-step
dependent inhibitory and stimulatory functions of Cpx. Concerning
the ﬁrst 25 amino acids of CpxI, in vivo studies revealed that this
highly conserved region plays a stimulatory role, but the molecular
mechanism still remains to be elucidated [19,22]. Recent in vitro
liposome fusion experiments showed that the carboxy-terminal
domain of CpxI stimulates SNARE-mediated liposome fusion [20].
Mutations in S115, a putative phosphorylation site, abolish thislsevier B.V. All rights reserved.
2344 F. Seiler et al. / FEBS Letters 583 (2009) 2343–2348stimulation. We now demonstrate that the amino acids ﬂanking
S115 are part of a conserved sequence, containing an amphipathic
helix, which confers lipid binding. Mutations in the hydrophobic
face of this helix alter the lipid binding and liposome fusion-stim-
ulating properties of CpxI.
2. Materials and methods
2.1. Liposome preparation
All lipids were purchased from Avanti Polar Lipids. The chloro-
form stock solutions of all lipids were stored under N2 at 20 C.
Lipid stock solutions were mixed in round bottom glass ﬂasks to
obtain a lipid mixture which is composed of 65 mol% POPC (1-pal-
mitoyl-2-oleoyl-SN-glycero-3-phosphatidylcholine) and 35 mol%
DOPS (1,2-dioleoyl-SN-glycero-3-phosphatidylserine). Evaporating
chloroform with a stream of N2 gas formed a homogenous lipid
ﬁlm. To remove residual solvent, the sample was further dried un-
der vacuum for 1 h. The lipid ﬁlm was rehydrated in reconstitution
buffer (25 mM HEPES (2-[4-(2-hydroxyethyl)-1-piperazinyl]-eth-
anesulfonic acid), pH 7.4, 100 mM KCl) at 37 C for 1 h to obtain
a lipid concentration of 10 mM. Following 10 cycles of freezing
(dry ice in isopropanol) and thawing (37 C water bath), the lipo-
somes were passed 8 times through 50 nm ﬁlters (Nuclepore
track-etched polycarbonate membrane, Whatman) using a LIPEX
Extruder (Northern lipids).
2.2. Liposome ﬂotation assay
Liposomes were prepared as described above. 14 lM CpxI was
incubated with liposomes, containing 4 mM lipids in ﬂotation buf-
fer (25 mM HEPES, pH 7.4, 500 mM KCl, 1 mM EGTA (ethylene gly-
col-bis(2-aminoethylether)-N,N,N0,N0-tetraacetic acid), 1 mM DTT
(1,4-dithiothreitol)) for 1 h at room temperature. After the incuba-
tion, 125 ll of the sample were mixed with 125 ll 80% Nycodenz
(5-(N-2,3-dihydroxypropylacetamido)-2,4,6-tri-iodo-N,N0-bis(2,3-
dihydroxypropyl)isophthalamide, Axis-Shield) in ﬂotation buffer
to yield a ﬁnal concentration of 40% Nycodenz. The sample wasA
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Fig. 1. An amphipathic helix in the carboxy-terminus of complexins. (A) Alignment of th
the Drosophila melanogaster complexin (dmCpx) using the T-COFFEE algorithm. The amp
(EMBOSS toolkit pepwheel, modiﬁed). Hydrophobic residues are highlighted in yellow, p
marked with arrows.overlayed with 400 ll 35% Nycodenz, 400 ll 30% Nycodenz and
200 ll buffer. After ultracentrifugation in a TLS-55 rotor (Beckman
Coulter) at 55 000 rpm for 3 h, the gradient was fractionated
(100 ll fractions) from the top.
Fractions were subjected to 15% (w/v) SDS–PAGE, followed by
Western blotting. CpxI constructs were detected with the poly-
clonal rabbit antibody SM193 and were visualized with an
Alexa688 coupled secondary antibody (Invitrogen) using an Odys-
sey infrared imaging system (LI-COR Bioscience).
2.3. Acrylamide quenching
Liposomes were prepared as described above. 4 lM and lipo-
somes, containing 1 mM lipids, were mixed and incubated for
30 min at 25 C in quenching buffer (25 mM HEPES, pH 7.4,
100 mM KCl, 250 mM acrylamide, 1 mM DTT). Samples were ex-
cited at 280 nm and the emission spectra were taken with a FP-
6500 ﬂuorescence spectrometer (JASCO) between 300 and
500 nm. After the ﬁrst measurement, 1 mM CaCl2 was added di-
rectly to the samples and a second data set was subsequently ta-
ken. In order to normalize the data, the spectrum of the buffer
was subtracted from the Cpx containing spectra and the spectrum
of the liposomes alone was subtracted from the spectra of the Cpx/
liposome mixture. Spectra displayed show one representative
experiment. Experiments were repeated several times indepen-
dently, yielding virtually identical results.
2.4. Protein reconstitution into liposomes
For donor liposomes 62 mol% POPC, 35 mol% DOPS, 2 mol% Rho-
damine-DPPE (N-(lissamine rhodamine B sulfonyl) 1,2-dipalmitoyl
phosphatidylethanolamine) and 1 mol% NBD-DPPE (N-(7-nitro-
2,1,3-benzoxadiaziole-4-yl)-1,2-dipalmitoyl phosphatidylethanol-
amine) were mixed resulting in 3 mM total lipid. The 15 mM total
lipid acceptor lipid mix contains 65 mol% POPC, 35 mol% DOPS. Fi-
nal lipid concentrations after ﬂotation were determined by using
parallel reconstitutions, which contained 1 mol% Rhodamine-DPPE
in the acceptor and donor liposomes.IIIxpCsh
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or t-SNARE complex (1 mg/ml) in 1% octyl-b-D-glucopyranoside
using the donor and acceptor lipid mixes deﬁned above, and the
previously described technique of dilution and dialysis followed
by a Nycodenz gradient centrifugation [3,20]. Protein lipid ratios
were 1/150, and 1/210 for VAMP2 and stx1/SNAP-25 liposomes,
respectively. Protein expression and puriﬁcation are described in
detail in the Supplementary material.
2.5. Fusion assay
Fusion reactions and data analysis were performed as de-
scribed previously [3] with the following modiﬁcations: (a) In
all cases, 30 ll of acceptor (unlabelled) and 5 ll of donor (labeled)
liposomes were used, (b) acceptor and donor liposomes were pre-
incubated on ice for 15 min in the presence or absence of different
Cpx constructs. The cold microtiter plate was transferred into a
Synergy4 plate reader (Biotek) and samples were measured at
intervals of 30 s for 30 min at 37 C. (c) The fusion-dependent
ﬂuorescence is normalized to the maximal ﬂuorescence signal ob-
tained in the presence of 0.4% dodecyl-b-D-maltoside. Fusion
kinetics displayed show one representative experiment. In
Fig. 3C, the results of the fusion assays were quantiﬁed by sub-
tracting the signals of the VAMP CD-containing reaction from
the other fusion reactions. The NBD ﬂuorescence after 10 min
was used as an indicator for the fusion kinetics. Fluorescence
intensity of the control reaction was set as 100% and the other
reactions were calculated accordingly. The error was calculated
as standard error of the mean from three independent
experiments.1
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Fig. 2. CpxI interacts with liposomes. (A) Schematic drawing of the Nycodenz gradien
fractions were collected for further analysis. (B) Prior to ﬂotation 1% of the total reacti
detected by Western blot analysis using an anti-CpxI antibody. (D) and (E) Tryptopha
acrylamide. Tryptophan residues, which dip into the membrane, were not quenched and
measured.3. Results
3.1. The carboxy-terminus of Cpx contains an amphipathic helix
To identify the molecular mechanism that underlies the stimu-
latory role of the CpxI carboxy-terminus in liposome fusion, we
analyzed the region ﬂanking amino acid serine 115. The sequence
alignment of Cpx homologues shows a cluster of negatively
charged amino acids that precedes S115 (Fig. 1A), followed by a
short amphipathic helix, which covers approximately 3 helix turns
and is terminated by a proline that is conserved in CpxI–III
(Fig. 1B). Drosophila Cpx apparently lacks the conserved serine
and the amphipathic helix in this region.
3.2. The amphipathic helix binds liposomes and dips into the lipid
bilayer
Since amphipathic helices are known to interact with mem-
branes, locally perturb the lipid bilayer, change the membrane cur-
vature, and can participate in membrane fusion processes, it was
tested if CpxI has the capability to bind membranes. Since the
amphipathic helix is short, a potential Cpx–lipid interaction might
be weak. To test if the amphipathic helix indeed binds lipid bilay-
ers, wild type and mutant CpxI constructs were incubated with lip-
osomes containing 65 mol% PC and 35 mol% PS. Liposomes were
reisolated by ﬂotation on a Nycodenz gradient, containing
500 mM KCl. High ionic strength was employed to focus primarily
on the hydrophobic interactions and to suppress ionic binding,
which could occur between the highly charged Cpxs and the lipid
bilayers. The recovered CpxI in the top fractions provides a mea-
surement for membrane binding (Fig. 2A). Wild type CpxI bindsC CpxI
V120P
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n ﬂuorescence in the buffer was quenched to a signiﬁcant degree with 250 mM
the change in their ﬂuorescence properties based on their microenvironment was
2346 F. Seiler et al. / FEBS Letters 583 (2009) 2343–2348to liposomes, and a point mutation at position 117, with leucine re-
placed by the bulky hydrophobic amino acid tryptophan (L117W),
showed an enhanced membrane interaction (Fig. 2C). In contrast,
mutations that convert this leucine into a charged amino acid
(L117K), or the introduction of the helix breaker proline (V120P),
dramatically reduce lipid binding. These results demonstrate that
the amphipathic helix confers lipid binding.
As an independent method to detect the lipid interaction, we
made use of the L117W mutant. Tryptophans are characterized
by an absorption maximum at 280 nm, but their emission peak
varies from 330 to 350 nm dependent on the local environment.
In a hydrophilic buffer, tryptophan emits at 350 nm, in a hydro-
phobic environment the peak is usually blue-shifted and the ﬂuo-
rescence intensity is increased. Since at steady state only a small
fraction of the Cpx population interacts with liposomes, acrylam-
ide was added to quench the tryptophan ﬂuorescence in the aque-
ous environment [25]. In this assay, we employed physiological
salt concentrations, which also allow ionic interactions. In addition
it was tested if calcium affects the CpxI–lipid binding, because the
cluster of negatively charged amino acids preceding the amphi-
pathic helix might interfere with the binding to the negatively
charged PS in the liposomes. When incubated with liposomes in
the absence of calcium a small blue-shift and an increase in theC
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Fig. 3. The interaction of the amphipathic helix of CpxI with membranes is essential for
liposomes were incubated in the absence or presence of the indicated complexin mutan
monitored for 30 min at 37 C. In order to show that the reaction is SNARE-dependent, w
complexes with the t-SNAREs on the t-SNARE liposomes, thereby inactivating the bindi
ﬂuorescence signal after detergent lysis. (C) Lipid mixing signals, 10 min after the s
(errorbars = S.E.M., three independent fusion assays). (D) Ten percent of the fusion reacemission peak of the W117 was detected (Fig. 2D). In the presence
of calcium, the ﬂuorescence intensity was further increased. When
PS was omitted from the liposomes, or when 500 mM KCl was
added during the incubation, the increase and blue-shift of the
W117 ﬂuorescence was prominent, but largely calcium-indepen-
dent (data not shown). A control tryptophan introduced at position
101 (I101W), which is not part of the amphipathic helix, did not
show any signiﬁcant emission increase or blue-shift upon liposome
addition (Fig. 2E). Thus, the tryptophan residue at position 117 dips
into the hydrophobic core of the lipid bilayer, in a manner that de-
pends on the local charge environment.
3.3. The amphipathic helix modulates the membrane fusion properties
of CpxI
Having identiﬁed a lipid bilayer-binding site in CpxI, the ques-
tion arises if this interaction is of functional relevance. In the sim-
plest case, the local interaction of the amphipathic helix with the
lipid bilayer would change the membrane structure and affect
membrane fusion. To test this hypothesis, we made use of a
well-established reconstituted lipid-mixing assay [3,26]. v-SNARE
liposomes contain VAMP2 and a quenched pair of NBD- and rhoda-
mine-labeled lipids. The acceptor t-SNARE liposomes contain stx1stx1
SNAP-25
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the assembly of the SNARE complex. It binds to the assembled t-SNARE (syntaxin 1
in orange and SNAP-25 in green) and prevents VAMP2 (red) from zippering up. (The
amino-terminal Habc domain of syntaxin 1 is not shown.) The amphipathic helix at
the carboxy-terminus of CpxI binds either the secretory vesicle or the plasma
membrane. (The model shows an interaction with the vesicle.) It still needs to be
determined at which exact stage of the fusion process the amphipathic helix
interacts with the lipid bilayer.
F. Seiler et al. / FEBS Letters 583 (2009) 2343–2348 2347and SNAP-25 but lack the ﬂuorophores. Fusion of these liposomes
results in ﬂuorescence dequenching and an increase of NBD-ﬂuo-
rescence. We employed conditions of a moderate stimulation of
membrane fusion upon the addition of wild type CpxI (Fig. 3A).
When the CpxI L117K mutant was added to the fusion reaction,
the fusion kinetics was comparable to the control reaction lacking
CpxI (Fig. 3A). In contrast, the addition of CpxI L117W signiﬁcantly
stimulated the fusion kinetics (Fig. 3A). Lipid mixing was SNARE-
dependent, because the addition of the cytoplasmic domain of
VAMP2 abolished the fusion signal. To further analyze if this stim-
ulatory effect depends on the CpxI–SNARE interaction, we intro-
duced point mutations in the central helix of CpxI (R48L/R59H)
that abolish SNARE binding. This triple CpxI R48L/R59H/L117W
mutant completely lost its stimulatory potential (Fig. 3B). As ex-
pected, the CpxI I101W had only moderate effects, in contrast to
the CpxI V120P mutant, which completely abolished the stimula-
tory effect of CpxI (Fig. 3B). Fig. 3C shows a quantitative analysis
of the different Cpx mutants 10 min after the start of the reactions.
Fig. 3D demonstrates that equal amounts of the distinct CpxI con-
structs were added to the fusion reactions. Thus, the carboxy-ter-
minal amphipathic helix of CpxI modulates lipid mixing in a
SNARE- and lipid-interaction-dependent manner.
4. Discussion
This study shows that at least some Cpxs contain an amphi-
pathic helix at their carboxy-terminus. Our analyses using CpxI
demonstrate that this amphipathic helix binds lipid bilayers. A
cluster of negatively charged amino acids preceding the amphi-
pathic helix can apparently modulate the lipid interaction as sup-
ported by our data. Thus, both ionic and hydrophobic interactions
affect the lipid interaction. Indeed, dependent on the local lipid
composition, calcium enhances the CpxI–membrane interaction.
This result is consistent with a recent publication showing that
CpxI stimulates liposome fusion in a calcium- and lipid-dependent
manner [21]. Our data directly demonstrates a role of the hydro-
phobic face of the amphipathic helix in lipid binding and SNARE-
dependent liposome fusion, measured by a lipid mixing assay.
The overall interaction of CpxI with the lipid bilayer is relatively
weak, but in the presence of SNAREpins, CpxI will be concentrated
at fusion sites. Thus, the Cpx–lipid interaction will occur in a highly
focused manner. Indeed, the simple presence of CpxI in the fusion
assay does not affect membrane fusion, when the CpxI–SNARE
interaction is abolished. Remarkably, the introduction of a trypto-
phan at position 117 signiﬁcantly enhances the stimulatory effect
of CpxI in membrane fusion. Since tryptophan is a bulky aminoacid, it is likely that the insertion of tryptophan into the membrane
induces positive membrane curvature. Recent publications showed
that similar amino acid substitutions in the hydrophobic loops of
the C2 domains of synaptotagmin I also enhance membrane fusion
in vitro and in vivo [27–30]. Furthermore, mutations in Ser 115
also affect liposome fusion indicating that the hydrophilic face of
the amphipathic helix might participate in Cpx–protein interac-
tions, linking the lipid interaction to the fusion apparatus [20,31].
Since membrane fusion is a multiple step process and the local
lipid composition at fusion sites is unknown, it is difﬁcult to pre-
dict the exact function of the Cpx–lipid interaction. For example,
several SNAREpins accumulate at the fusion site, and coherently
multiple Cpx–lipid interactions could create a unique lipid envi-
ronment that stalls or accelerates distinct fusion intermediates
(e.g. affect the local induction of positive membrane curvature, or
hemifusion intermediates). In our assay, which uses high curvature
liposomes, the CpxI–lipid interaction clearly stimulates lipid mix-
ing. In the presence of appropriate lipids, the calcium-dependent
CpxI–lipid binding together with calcium-dependent synaptotag-
min/SNARE/lipid interactions could become an integral part of a
triggering mechanism opening the fusion pore or at least, function
in concert with synaptotagmins to deform the membrane. In addi-
tion, or alternatively, the CpxI–lipid interaction might have a mod-
ulatory role in the core fusion reaction.
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